Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Abstract Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels in malignant tumours. uPAR is closely related to the invasion and metastasis of malignant tumours, plays impo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bing-Tao Zhai, Huan Tian, Jing Sun, Jun-Bo Zou, Xiao-Fei Zhang, Jiang-Xue Cheng, Ya-Jun Shi, Yu Fan, Dong-Yan Guo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2022-03-01
Edice:	Journal of Translational Medicine
Témata:	Urokinase-type plasminogen activator receptor (uPAR) Nanoparticles (NPs) Photodynamic therapy (PDT)/photothermal therapy (PTT) Oncolytic virotherapy Gene therapy technologies Monoclonal antibody therapy
On-line přístup:	https://doi.org/10.1186/s12967-022-03329-3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!